arrow
Z

Zhijie An

chinese center for disease control and prevention
H指数:22
被引数:2,068

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity, immune persistence, and safety of japanese encephalitis vaccine schedules among adults in Ningxia, China

免疫原性、免疫持久性及安全性:中国宁夏成年人日本脑炎疫苗接种方案

2025-10-300
OA
Safety, Immunogenicity, and Effectiveness of Chinese-Made COVID-19 Vaccines in the Real World: An Interim Report of a Living Systematic Review

中国产新型冠状病毒肺炎疫苗的安全性、免疫原性和真实世界有效性:一项动态系统评价的中期报告

2024-07-161
OAAI
Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCoV boosters and BA.2 infection

与注射和雾化Ad5-nCoV加强剂和BA.2感染相关的中和抗体水平

2023-07-038
OAAI
Effectiveness of Inactivated COVID-19 Vaccines against Delta-Variant COVID-19: Evidence from an Outbreak in Inner Mongolia Autonomous Region, China

灭活新型冠状病毒肺炎疫苗对三角洲变异新型冠状病毒肺炎的有效性: 来自中国内蒙古自治区暴发的证据

2023-01-285
OAAI
Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination

与两种灭活新型冠状病毒肺炎疫苗在初次系列疫苗接种后12个月诱导的中和抗体水平相关的因素

2022-09-099
OAAI
A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants

中国生产的新型冠状病毒肺炎疫苗的初次和加强预防接种对预防Delta和Omicron变体感染的疫苗接种者的肺炎和病毒载量的影响的病例研究

2022-08-054
OAAI
Effectiveness of Inactivated COVID-19 Vaccines Against Symptomatic, Pneumonia, and Severe Disease Caused by the Delta Variant: Real World Study and Evidence - China, 2021
2022-01-0140
OA